Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy

Leukemia. 2020 Nov;34(11):3064-3069. doi: 10.1038/s41375-020-0760-x. Epub 2020 Feb 26.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, CD19 / genetics
  • Antigens, CD19 / metabolism*
  • Antineoplastic Agents, Immunological / pharmacology
  • Antineoplastic Agents, Immunological / therapeutic use
  • Cell Membrane / metabolism*
  • Child
  • Gene Expression
  • Humans
  • Leukemia, B-Cell / genetics
  • Leukemia, B-Cell / immunology
  • Leukemia, B-Cell / metabolism*
  • Leukemia, B-Cell / therapy
  • Lymphoma, B-Cell / genetics
  • Lymphoma, B-Cell / immunology
  • Lymphoma, B-Cell / metabolism*
  • Lymphoma, B-Cell / therapy
  • Molecular Targeted Therapy
  • Prognosis
  • Treatment Outcome

Substances

  • Antigens, CD19
  • Antineoplastic Agents, Immunological